Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Combinatorial delivery of low-dose radiotherapy and immunotherapy to patients with immune-excluded tumors enhances CD8+ T cell functionality.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Same author

Cancer immunotherapy insights: key takeaways from the ADSCC bone marrow and cellular therapy congress 2024.

Frontiers in immunology·2026

Same author

Highly efficient gene knockout in tumor-infiltrating lymphocytes by adenine base editing.

Molecular therapy. Oncology·2025

Same author

The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee.

Journal for immunotherapy of cancer·2025

Same author

Multi-modal image analysis for large-scale cancer tissue studies within IMMUcan.

Cell reports methods·2025

Same author

Immune correlates and mechanisms of TIL therapy efficacy: current insights and knowledge gaps.

Trends in cancer·2025

Search research articles

Related Experiment Video

Updated: May 9, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Deciphering and reversing tumor immune suppression.

Greg T Motz¹, George Coukos

¹Ovarian Cancer Research Center, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.

|July 30, 2013

Summary

This summary is machine-generated.

Tumors evade anti-tumor immunity by disabling effector T cells through various immunosuppressive strategies. This review explores these mechanisms and highlights novel therapies aimed at restoring immune responses for improved patient survival.

More Related Videos

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8⁺ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Published on: January 29, 2019

Related Experiment Videos

Last Updated: May 9, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8⁺ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Published on: January 29, 2019

Area of Science:

Immunology
Oncology
Cancer Research

Background:

Effective anti-tumor immunity relies on effector T cells recognizing and eliminating cancer cells.
Tumors actively suppress anti-tumor immune responses through multiple complex mechanisms.
These mechanisms include interfering with antigen presentation, hindering immune cell infiltration, and recruiting immunosuppressive cells.

Purpose of the Study:

To review the diverse strategies employed by tumors to suppress anti-tumor immunity.
To highlight emerging therapeutic approaches designed to overcome tumor-induced immune suppression.
To emphasize the importance of understanding immune evasion for advancing cancer immunotherapy.

Main Methods:

Literature review of scientific publications on tumor immunology and immunotherapy.
Analysis of mechanisms by which tumors evade immune surveillance.
Synthesis of current and emerging therapeutic strategies targeting tumor immunosuppression.

Main Results:

Tumors utilize multifaceted approaches to dampen T-cell-mediated anti-tumor responses.
Key immunosuppressive strategies involve antigen-presenting cell dysfunction, vascular barriers, and the induction of regulatory immune cells.
New therapies are being developed to reverse these suppressive effects and enhance anti-tumor immunity.

Conclusions:

Understanding tumor immune evasion is critical for developing effective cancer immunotherapies.
Reversing tumor-induced immunosuppression holds significant promise for improving patient outcomes.
Further research into these mechanisms will drive the next generation of anti-cancer treatments.